Depletion of CD8+ cells by anti-CD8 mAb was performed to investigate the relationship between tumor growth inhibition and tumor-specific CD8+ T cells activated by combination therapy, especially the distant tumors. The gene discussed is CD8A; the disease is neoplasm.